Valacyclovir Export Market Intelligence: India's 113 Suppliers Shipping to 70 Countries — TransData Nexus 2026

Q: Who are the top valacyclovir exporters from India?

The top valacyclovir exporters from India are: 1. MYLAN LABORATORIES LIMITED — $46.4M (49.8% market share); 2. HETERO LABS LIMITED — $33.9M (36.4% market share); 3. AUROBINDO PHARMA LTD — $8.1M (8.7% market share); 4. V S INTERNATIONAL PRIVATE LIMITED — $1.3M (1.4% market share); 5. AUROBINDO PHARMA LIMITED — $935.5K (1.0% market share). Together they account for 97.3% of India's total valacyclovir export value.

Q: What is the total export value of valacyclovir from India?

The total export value of valacyclovir from India is $93.2M USD, recorded across 2,537 shipment transactions from 113 active exporters to 70 destination countries. The average shipment value is $36.7K.

Q: Which countries import valacyclovir from India?

India exports valacyclovir to 70 countries worldwide. The top importing countries are: UNITED STATES (87.2% share, $81.2M), CANADA (4.0% share, $3.7M), TAIWAN (3.3% share, $3.0M), SWEDEN (2.0% share, $1.9M), SAUDI ARABIA (0.7% share, $611.4K). These five markets account for 97.1% of total export value.

Q: What is the HS code for valacyclovir exports from India?

The primary HS code for valacyclovir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of valacyclovir exports from India?

The average unit price for valacyclovir exports from India is $3.32 USD per unit, with prices ranging from $0.01 to $251.00 depending on formulation, packaging, and order volume. The total market is valued at $93.2M across 2,537 shipments.

Q: Which ports handle valacyclovir exports from India?

The primary ports for valacyclovir exports from India are DELHI AIR CARGO ACC (INDEL4) (22.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (19.5% of shipments), SAHAR AIR (14.4% of shipments), DELHI AIR (12.3% of shipments), Delhi Air (4.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of valacyclovir?

India is one of the world's leading exporters of valacyclovir due to its large base of 113 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports valacyclovir to 70 countries, demonstrating 36% global market coverage.

Q: What certifications do Indian valacyclovir exporters need?

Indian valacyclovir exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import valacyclovir from India?

There are 197 registered buyers importing valacyclovir from India, spread across 70 countries. The repeat buyer rate is 61.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top valacyclovir supplier from India?

MYLAN LABORATORIES LIMITED is the leading valacyclovir exporter from India with a market share of 49.8% and total export value of $46.4M across 62 shipments. The top 5 suppliers together control 97.3% of total export value.

Suresh Sormare

Valacyclovir

India Pharmaceutical Trade Intelligence

$93.2M113 Suppliers70 CountriesHS 30049099

ExportsIndia → UNITED STATES87.2%India → CANADA4.0%

ImportsUNITED STATES → India$11.1K GERMANY → India$3.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

How India Exports Valacyclovir to the World

Between 2022 and 2026, India exported $93.2M worth of valacyclovir across 2,537 verified shipments to 70 countries — covering 36% of world markets in the Antivirals segment. The largest destination is UNITED STATES (87.2%). MYLAN LABORATORIES LIMITED leads with a 49.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Valacyclovir export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Valacyclovir export data snapshot — $93.2M · 113 exporters · 70 countriesTransData Nexus · Indian Customs Data

Top Valacyclovir Exporters from India

113 active exporters · Ranked by export value

View all 113 →

Top Valacyclovir Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$46.4M	62	3	49.8%
2	HETERO LABS LIMITED

Top Countries Importing Valacyclovir from India

70 destination markets · Ranked by import value

All 70 countries →

Top Countries Importing Valacyclovir from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$81.2M	87.2%
2	CANADA	$3.7M	4.0%
3	TAIWAN	$3.0M	3.3%
4	SWEDEN	$1.9M	2.0%
5	SAUDI ARABIA	$611.4K	0.7%
6	SINGAPORE	$359.4K	0.4%
7	RUSSIA	$345.0K	0.4%
8	AUSTRALIA	$284.5K	0.3%
9	MALAYSIA	$265.7K	0.3%
10	PHILIPPINES	$258.9K	0.3%

UNITED STATES is India's largest valacyclovir export destination, absorbing 87.2% of total exports worth $81.2M. The top 5 importing countries — UNITED STATES, CANADA, TAIWAN, SWEDEN, SAUDI ARABIA — together account for 97.1% of India's total valacyclovir export value. The remaining 65 destination countries collectively receive the other 2.9%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Valacyclovir to India?

5 origin countries · Total import value: $18.3K

India imports valacyclovir from 5 countries with a combined import value of $18.3K. The largest supplier is UNITED STATES ($11.1K, 19 shipments), followed by GERMANY and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Valacyclovir to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$11.1K	19	60.6%
2	GERMANY	$3.4K	2	18.8%
3	CANADA	$1.9K	5	10.5%
4	BULGARIA	$1.6K	2	8.7%
5	SOUTH AFRICA	$266	2	1.5%

UNITED STATES is the largest supplier of valacyclovir to India, accounting for 60.6% of total import value. The top 5 origin countries — UNITED STATES, GERMANY, CANADA, BULGARIA, SOUTH AFRICA — together supply 100.0% of India's valacyclovir imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Valacyclovir

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, valacyclovir is marketed under the brand name Valtrex, originally approved by the FDA in January 1997. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for generic versions of valacyclovir, indicating a competitive market landscape. Notably, Indian manufacturers such as Mylan Laboratories Limited and Hetero Labs Limited have secured significant market shares, with export values of $46.4 million (49.8%) and $33.9 million (36.4%) respectively. As of March 2026, there are no active FDA import alerts specifically targeting valacyclovir imports from India, suggesting compliance with U.S. regulatory standards.

2EU & UK Regulatory Framework

In the European Union, valacyclovir is authorized under various brand names, including Valtrex. In July 2010, the European Medicines Agency (EMA) harmonized the prescribing information for Valtrex across member states to ensure consistent therapeutic indications and dosing regimens. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA guidelines, requiring adherence to Good Manufacturing Practice (GMP) standards for all pharmaceutical imports. Indian exporters must ensure compliance with these stringent requirements to access the EU and UK markets.

3WHO Essential Medicines & Global Standards

Valacyclovir is included in the World Health Organization's Model List of Essential Medicines, underscoring its importance in global health. While specific editions of the list are not detailed here, its inclusion signifies recognition of valacyclovir's therapeutic value. The drug is also subject to international pharmacopoeia standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality and efficacy across different markets.

4India Regulatory Classification

In India, valacyclovir is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, valacyclovir is not listed under the Drug Price Control Order (DPCO), allowing manufacturers to set prices based on market dynamics. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national and international regulations.

5Patent & Exclusivity Status

The primary patents for valacyclovir have expired, leading to the availability of generic versions and increased competition in the market. This has facilitated the entry of multiple Indian pharmaceutical companies into the global market, contributing to the substantial export figures observed.

6Recent Industry Developments

In June 2025, the NPPA conducted a review of antiviral drug prices, including valacyclovir, to assess market trends and ensure affordability. In September 2025, the EMA updated its GMP guidelines, emphasizing stricter quality control measures for active pharmaceutical ingredients (APIs), impacting Indian exporters supplying to the EU. In December 2025, the FDA issued a guidance document on the stability testing of generic drugs, affecting ANDA holders, including those for valacyclovir. In February 2026, the WHO released a report highlighting the global demand for antiviral medications, noting a 15% increase in valacyclovir usage over the past year. In March 2026, the DGFT introduced an online portal for faster processing of export NOCs, streamlining the export process for pharmaceutical companies.

These developments reflect the dynamic regulatory environment affecting valacyclovir exports from India, necessitating continuous monitoring and compliance by stakeholders to maintain market access and competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Valacyclovir

Retail & reference prices across 9 markets vs. India FOB export price of $3.32/unit

Global Price Benchmark for Valacyclovir across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.50	USD	According to the FDA's Orange Book, Valacyclovir is approved for generic manufacturing, contributing to competitive pricing.
United Kingdom	$2.30	GBP	The NHS Drug Tariff, updated in February 2026, lists Valacyclovir 500mg tablets at £1.80 per unit.
Germany	$2.20	EUR	The Federal Joint Committee (G-BA) sets the reimbursement price for Valacyclovir 500mg tablets at €2.00 as of January 2026.
Australia	$2.10

Supply Chain Risk Assessment — Valacyclovir

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Valacyclovir, an antiviral medication, relies on specific Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) for its production. India, a major exporter of Valacyclovir, sources a significant portion of these KSMs from China. According to the U.S. Pharmacopeia, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting a critical dependency. This reliance poses a risk, as any disruption in the supply chain from China can directly impact the availability of Valacyclovir APIs in India.

Recent geopolitical tensions and trade disputes have exacerbated this vulnerability. For instance, in October 2025, the U.S. Pharmacopeia reported that 58% of KSMs used for U.S.-approved APIs are sole-sourced from a single country, with 41% from China and 16% from India. Such dependencies underscore the need for diversification in sourcing strategies to mitigate potential supply chain disruptions.

2Supplier Concentration & Single-Source Risk

The export data for Valacyclovir from India reveals a high supplier concentration, with the top five exporters accounting for 97.3% of the total export value. Notably, MYLAN LABORATORIES LIMITED alone contributes 49.8% of this share. This concentration indicates a significant single-source risk, as any operational or regulatory issues affecting these key suppliers could disrupt the global supply of Valacyclovir.

Access Complete Valacyclovir Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,537 transactions across 70 markets.

Request Demo View Pricing

Frequently Asked Questions — Valacyclovir Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top valacyclovir exporters from India?

The leading valacyclovir exporters from India are MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, AUROBINDO PHARMA LTD, and 11 others. MYLAN LABORATORIES LIMITED leads with 49.8% market share ($46.4M). The top 5 suppliers together control 97.3% of total export value.

What is the total export value of valacyclovir from India?

The total export value of valacyclovir from India is $93.2M, recorded across 2,537 shipments from 113 active exporters to 70 countries. The average shipment value is $36.7K.

Which countries import valacyclovir from India?

India exports valacyclovir to 70 countries. The top importing countries are UNITED STATES (87.2%), CANADA (4.0%), TAIWAN (3.3%), SWEDEN (2.0%), SAUDI ARABIA (0.7%), which together account for 97.1% of total export value.

What is the HS code for valacyclovir exports from India?

The primary HS code for valacyclovir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Valacyclovir Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

Valacyclovir

Valacyclovir

Top Valacyclovir Exporters from India

Top Countries Importing Valacyclovir from India

Who Supplies Valacyclovir to India?

Quick Facts

Related Antivirals

Related Analysis

Need Details?

Regulatory Landscape — Valacyclovir

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Valacyclovir

Supply Chain Risk Assessment — Valacyclovir

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Valacyclovir Trade Intelligence

Frequently Asked Questions — Valacyclovir Exports from India

Who are the top valacyclovir exporters from India?

What is the total export value of valacyclovir from India?

Which countries import valacyclovir from India?

What is the HS code for valacyclovir exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of valacyclovir exports from India?

Which ports handle valacyclovir exports from India?

Why is India a leading exporter of valacyclovir?

What certifications do Indian valacyclovir exporters need?

How many buyers import valacyclovir from India?

What is the market share of the top valacyclovir exporter from India?

Analysis Methodology